Association between number of actionable pharmacogenetic variants and length of hospital stay

Joseph Finkelstein, Frederick Zhang, Manuel Cabrera

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

1 Scopus citations

Abstract

The goal of this study was to evaluate association between number of pharmacogenetic variants and length of hospital stay. Electronic medical records were combined with exome sequencing results in 450 hospitalized patients. De-identified data set was used to characterize urgent care utilization and to identify presence of 44 actionable pharmacogenetic variants according to the guidelines of the Clinical Pharmacogenetics Implementation Consortium. The average age was 58.03 ± 16.47 ranging from 20 to 91 years old, average number of pharmacogenetic variants was 61.22 ± 26.52 ranging from 20 to 169, and mean length of hospital stay was 6.50 ± 4.29 ranging between 1 and 42 days. After adjusting for patient socio-demographics and overall disease severity reflected by the Charlson comorbidity index, a significant association between mean length of stay and number of pharmacogenetic variants was found using generalized linear regression (p-value < 2.2e-16).

Original languageEnglish
Title of host publicationTHE IMPORTANCE OF HEALTH INFORMATICS IN PUBLIC HEALTH DURING A PANDEMIC
EditorsJohn Mantas, Arie Hasman, Mowafa S. Househ, Parisis Gallos, Emmanouil Zoulias
PublisherIOS Press
Pages195-198
Number of pages4
ISBN (Electronic)9781643680927
DOIs
StatePublished - 2020

Publication series

NameStudies in Health Technology and Informatics
Volume272
ISSN (Print)0926-9630
ISSN (Electronic)1879-8365

Keywords

  • Pharmacogenetics
  • allelic variation
  • electronic health record
  • hospitalization

Fingerprint

Dive into the research topics of 'Association between number of actionable pharmacogenetic variants and length of hospital stay'. Together they form a unique fingerprint.

Cite this